Product Classification
- drug impurity
- drug standards
- Metaraminol bitartrate
- analytical chemistry
- standard substances
- chemical custom synthesis
- Azithromycin
- Atorvastatin
- (S)-Cinacalcet
- Ilaprazole
- Tranexamic Acid
- Duloxetine
- Octreotide
- Budesonide
- Carboprost Trometamol
- Minocycline
- Dobutamine
- Netupitant
- Axitinib
- Omadacycline
- Brivaracetam
- Metoprolol
- Indobufen
- Empagliflozin
- Dapagliflozin
- Acetylcysteine
- Hydroxychloroquine
- Tegoprazan
- Lenalidomide
- Canagliflozin
- Bromocriptine
- Rasagiline
- Bortezomib
- Diclofenac
- Bisoprolol
- Rocuronium Bromide
- Esmolol
- Bromhexine
- Probucol
- Formoterol
- Crisaborole
- Pitavastatin (3S,5S)-Isomer Calcium
- Bumetanide
- Dotinurad
- Fulvestrant
- Dotinurad
- Landiolol
Contact us
Tel:+86 17320513646
Phone:+86 17320513646
Website:https://www.moxinchem.com
Email: mike@molcoo.com
Address:Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China

24997-88-4
- Product Name:Dobutamine Impurity
- Molecular Formula:
- Purity:99%
- Molecular Weight:345.439
Product Details;
CasNo: 24997-88-4
Factory Sells Best Quality Dobutamine Impurity 24997-88-4 with ISO standards
- Molecular Formula:C20H27NO4
- Molecular Weight:345.439
24997-88-4 Relevant articles
Trapping of iminiums by the indole nucleus during catalytic hydrogenation of nitriles: A rapid synthesis of tetrahydro-β-carbolines
Diker, Khalid
, p. 2497 - 2500 (2007/10/02)
Reductive self-condensation of indole ac...
Compounds having calcium blocking activity
-
, (2008/06/13)
Compound of general formula I STR1 and i...
Studies on the syntheses of heterocyclic compounds. CCXII. By-product in the prepatation of homoveratrylamine by catalytic hydrogenation of 3,4-dimethoxybenzyl cyanide and its derivation to 2-phenethylisoquinoline derivatives
Kametani,Ogasawara,Harada
, p. 163 - 165 (2007/10/05)
-
24997-88-4 Process route
-
-
93-17-4
3,4-dimethoxyphenylacetonitrile

-
-
24997-88-4
N-<2-(3,4-dimethoxyphenyl)ethyl>-2-(3,4-dimethoxyphenyl)ethylamine

-
-
120-20-7
2-(3,4-dimethoxyphenyl)-ethylamine

-
-
Tris-[2-(3,4-dimethoxy-phenyl)-ethyl]-amine
Conditions | Yield |
---|---|
With
hydrogen;
palladium on activated charcoal;
In
acetic acid;
for 48h;
|
10% 35% 35% |
-
-
93-17-4
3,4-dimethoxyphenylacetonitrile

-
-
24997-88-4
N-<2-(3,4-dimethoxyphenyl)ethyl>-2-(3,4-dimethoxyphenyl)ethylamine

-
-
120-20-7
2-(3,4-dimethoxyphenyl)-ethylamine
Conditions | Yield |
---|---|
With
ethanol; nickel;
at 90 ℃;
under 58840.6 Torr;
Hydrogenation;
|
24997-88-4 Upstream products
-
3,4-dimethoxyphenylacetonitrile
-
2-(3,4-dimethoxyphenyl)-ethylchloride
-
2-(3,4-dimethoxyphenyl)-ethylamine
-
2-(3,4-dimethoxyphenyl)ethyl alcohol
24997-88-4 Downstream products
-
4,4'-(3-aza-pentanediyl)-di-pyrocatechol
-
bis-N-<2-(3,4-dimethoxyphenyl)ethyl>trifluoroacetamide
Related products
-
Esmolol ImpurityDetail
CAS:98903-90-3
$ -
Bortezomib ImpurityDetail
CAS:886979-81-3
$ -
Minocycline EP Impurity FDetail
CAS:1075240-33-3
$ -
Netupitant ImpurityDetail
CAS:910808-11-6
$